Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ZIFRZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Rituximab-GDP-D-P2/P8-P4-GGFG-Dxd
|
|||||
| Synonyms |
Rituximab-GDP-D-P2/P8-P4-GGFG-Dxd
Click to Show/Hide
|
|||||
| Organization |
Yantang Biotechnology (Hangzhou) Co., Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Rituximab
|
Antibody Info | ||||
| Antigen Name |
B-lymphocyte antigen CD20 (MS4A1)
|
Antigen Info | ||||
| Payload Name |
DX-8951 derivative (DXd)
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
CN119326907A Trastuzumab-GDP-D-P2/P8-P4-GGFG-Dxd Linker
|
Linker Info | ||||
| Conjugate Type |
Glycosyl coupling
|
|||||